Oral squamous cell carcinoma: review of prognostic and predictive factors

J Massano, FS Regateiro, G Januário… - Oral surgery, oral …, 2006 - Elsevier
Oral squamous cell carcinoma has a remarkable incidence worldwide and a fairly onerous
prognosis, encouraging further research on factors that might modify disease outcome. In …

Perspectives on oral squamous cell carcinoma prevention—proliferation, position, progression and prediction

PJ Thomson - Journal of Oral Pathology & Medicine, 2018 - Wiley Online Library
Squamous cell carcinoma arising from oral mucosal epithelium remains a lethal and
deforming disease due to tumour invasion, oro‐facial destruction, cervical lymph node …

Cellular Proliferation in Canine Cutaneous Mast Cell Tumors: Associations with c-KIT and Its Role in Prognostication

JD Webster, V Yuzbasiyan-Gurkan… - Veterinary …, 2007 - journals.sagepub.com
Canine cutaneous mast cell tumor (MCT) is a common neoplastic disease in dogs. Due to
the prevalence of canine MCTs and the variable biologic behavior of this disease, accurate …

Biomarkers of laryngeal squamous cell carcinoma: a review

M Cavaliere, A Bisogno, A Scarpa, A D'Urso… - Annals of Diagnostic …, 2021 - Elsevier
Laryngeal carcinoma is the second common malignancy of the upper aerodigestive tract
after lung cancer; in most cases is a squamous cell carcinoma, whose risk factors include …

Bringing the heavy: carbon ion therapy in the radiobiological and clinical context

CD Schlaff, A Krauze, A Belard, JJ O'Connell… - Radiation …, 2014 - Springer
Radiotherapy for the treatment of cancer is undergoing an evolution, shifting to the use of
heavier ion species. For a plethora of malignancies, current radiotherapy using photons or …

Granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor promote malignant growth of cells from head and neck squamous cell …

CM Gutschalk, CC Herold-Mende, NE Fusenig… - Cancer research, 2006 - AACR
Granulocyte colony-stimulating factor (G-CSF) and granulocyte-macrophage colony-
stimulating factor (GM-CSF) are used to ameliorate cancer therapy-induced neutropenia and …

The accuracy of survival time prediction for patients with glioma is improved by measuring mitotic spindle checkpoint gene expression

L Bie, G Zhao, P Cheng, G Rondeau, S Porwollik, Y Ju… - PloS one, 2011 - journals.plos.org
Identification of gene expression changes that improve prediction of survival time across all
glioma grades would be clinically useful. Four Affymetrix GeneChip datasets from the …

Disease mechanism and biomarkers of oral squamous cell carcinoma

BMN Brinkman, DTW Wong - Current opinion in oncology, 2006 - journals.lww.com
Important progress has been made in the molecular understanding of oral cancer and its
application for diagnosis, prognosis and treatment. The increased efforts in translational …

An integrative bioorthogonal nanoengineering strategy for dynamically constructing heterogenous tumor spheroids

Y Xu, A Zhou, W Chen, Y Yan, K Chen… - Advanced …, 2023 - Wiley Online Library
Although tumor models have revolutionized perspectives on cancer aetiology and treatment,
current cell culture methods remain challenges in constructing organotypic tumor with in vivo …

NRBF2-mediated autophagy contributes to metabolite replenishment and radioresistance in glioblastoma

J Kim, H Kang, B Son, MJ Kim, JH Kang… - … & Molecular Medicine, 2022 - nature.com
Overcoming therapeutic resistance in glioblastoma (GBM) is an essential strategy for
improving cancer therapy. However, cancer cells possess various evasion mechanisms …